Trial Profile
An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects with Androgenic Alopecia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Finasteride (Primary) ; Minoxidil
- Indications Alopecia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Dong-A ST
- 06 Nov 2017 Status changed from not yet recruiting to completed.
- 13 Jul 2016 New trial record